Coxsackievirus infections and NOD mice: Relevant models of protection from, and induction of, type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 1103, Issue , 2007, Pages 143-151

  Tracy, Steven ^a,c   Drescher, Kristen M ^b  

^a NEBRASKA MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Coxsackievirus; Enterovirus; IL 4; NOD mice; Non obese diabetic mice; T1D; Type 1 diabetes; cells

Indexed keywords

INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; COXSACKIE VIRUS; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; VIRUS INFECTION; VIRUS REPLICATION;

COXSACKIEVIRUS; ENTEROVIRUS; MURINAE; MUS;

EID: 34249090746     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1394.009     Document Type: Article

References (64)

1. TRACY, S., N. CHAPMAN & B. MAHY. 1997. The coxsackie B viruses. Curr. Top. Microbiol. Immunol. 223.
2. PALLANSCH, M. & R.P. ROOS. 2001 In Fields Virology. D.M. Knipe & P.M. Howley, Eds.: 723-776. Lipincott Williams and Wilkins, Philadelphia. PA.
3. ARNESJO, B., T. EDEN, I. IHSE, et al. 1976. Enterovirus infections in acute pancreatitis - a possible etiological connection. Scand. J. Gastroenterol. 11: 645-649.
4. TRACY, S. et al. 2000. Group B coxsackievirus myocarditis and pancreatitis in mice: connection between viral virulence phenotypes. J. Med. Virol. 62: 70-81.
5. URSING, B. 1973. Acute pancreatitis in coxsackie B infection. Brit. Med. J. 3: 524-525.
6. CHAMPSAUR, H. et al. 1980. Diabetes and coxsackievirus B5 infection. Lancet 1: 251-251.
7. CHEHADEH, W. et al. 2000. Increased level of interferon alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J. Infect. Dis. 181: 1929-1939.
8. NAIRN, C., D. GALBRAITH, K. TAYLOR & G.B. CLEMENTS. 1999. Enterovirus variants in the serum of children at the onset of type 1 diabetes mellitus. Diabet. Med. 16: 509-513.
9. RAMSINGH, A., N. CHAPMAN & S. TRACY. 1997. Coxsackieviruses and diabetes. Bioessays 19: 793-800.
10. MARIA, H., A. ELSHEBANI, O. ANDERS, et al. 2005. Simultaneous type 1 diabetes onset in mother and son coincident with an enteroviral infection. J. Clin. Virol. 33: 158-167.
11. VISKARI, H. et al. 2005. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 48: 1280-1287.
12. MOYA-SURI, V. et al. 2005. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with type 1-diabetes-associated autoantibodies. J. Med. Microbiol. 54: 879-883.
13. CABRERA-RODE, E. et al. 2005. Islet cell related antibodies and type 1 diabetes associated with echovirus 30 epidemic: a case report. J. Med. Virol. 76: 373-377.
14. YLIPAASTO, P. et al. 2004. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47: 225-239.
15. PAANANEN, A. et al. 2003. Molecular and biological analysis of echovirus 9 strain isolated from a diabetic child. J. Med. Virol. 69: 529-537.
16. DIAZ-HORTA, O. et al. 2001. Echovirus 4 and type 1 diabetes mellitus. Autoimmunity 34: 275-281.
17. CABRERA-RODE, E. et al. 2003. Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabetologia 46: 1348-1353.
18. WILLIAMS, C.H. et al. 2006. Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies. J. Clin. Microbiol. 44: 441-448.
19. FUCHTENBUSCH, M., A. IRNSTETTER, G. JAGER & A.-G. ZIEGLER. 2001. No evidence for an association of coxsackievirus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J. Autoimmun. 17: 333-340.
20. HIERHOLZER, J.C. & W. FARRIS. 1974. Follow-up of children infected in a coxsackievirus B3 and B4 outbreak: No evidence of diabetes mellitus. J. Infect. Dis. 129: 741-746.
21. HUFF, J.C., J.C. HIERHOLZER & W. FARRIS. 1974. An 'outbreak' of juvenile diabetes mellitus: consideration of a viral etiology. Am. J. Epidemiol. 100: 277-287.
22. GOLDACRE, M.J., C.J. WOTTON, D. YEATES, et al. 2005. Hospital admission for selected single virus infections prior to diabetes mellitus. Diabetes Res. Clin. Pract. 69: 256-261.
23. AKERBLOM, H.K., O. VAARALA, H. HYOTY, et al. 2002. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 115: 18-29.
24. HYOTY, H. & K.W TAYLOR. 2002. The role of viruses in human diabetes. Diabetologia 45: 1353-1361.
25. SIGURDSSON, E. & S. BAEKKESKOV. 1990. The 64-kDa beta cell autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus. Curr. Top. Microbiol. Immunol. 164: 143-168.
26. FOULIS, A.K. et al. 1990. A search for the presence of enteroviral capsid protein VP1 in pancreases of patients with type 1 diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetology 33: 290-298.
27. ROIVAINEN, M. et al. 2002. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45: 693-702.
28. CHEHADEH, W. et al. 2000. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J. Virol. 74: 10153-10164.
29. DRESCHER, K.M., K. KONO, S. BOPEGAMAGE, et al. 2004. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 329: 381-394.
30. KANNO, T.K.K., K. KONO, K.M. DRESCHER, et al. 2006. Group B coxsackievirus diabetogenic phenotype correlates with viral replication efficiency. J. Virol. 80: 5637-5643.
31. TRACY, S. et al. 2002. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: Inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76: 12097-12111.
32. MENA, I. et al. 2000. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology.Virology 271: 276-288.
33. FLODSTROM, M. et al. 2002. Target cell defense prevents the development of diabetes after viral replication. Nat. Immunol. 3: 373-382.
34. FLODSTROM-TULLBERG, M. et al. 2005. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J. Immunol. 174: 1171-1177.
35. HILTUNEN, M., M. LONNROT & H. HYOTY. 1999. Immunisation and type 1 diabetes mellitus: is there a link? Drug Saf. 20: 207-212.
36. 2000 Enterovirus surveillance - United States, 1997-1999. Morbidity Mortality Weekly Rep. 49: 913-916.
37. CONTROL, C. F.D. 2000. Non-polio enterovirus surveillance - United States 1993-1996. Morbidity Mortality Weekly Rep. 46: 748-750.
38. FROESCHLE, J., P. FEORINO & H.M GELFAND. 1966. A continuing surveillance of enterovirus infection in healthy children in six United States cities. II. Surveillance enterovirus isolates 1960-1963 and comparison with enterovirus isolates from cases of acute central nervous system disease. Am. J. Epidemiol. 83: 455-469.
39. ATKINSON, M.A. & E.H. LEITER. 1999. The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5: 601-604.
40. ROEP, B., M.A. ATKINSON & M.G. VON HERRATH. 2004. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat. Rev. Immunol. 4: 989-997.
41. WONG, F.S. & C.A., JR.. 1999. Insulin-dependent diabetes mellitus and its animal models. Curr. Opin. Immunol. 11: 643-647.
42. SERREZE, D.V. JANEWAY, E.W. OTTENDORFER, et al. 2000. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49: 708-711.
43. YOON, J., M. AUSTIN, T. ONODERA & A NOTKINS. 1979. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300: 1173-1179.
44. FILIPPI, C. & M. VON HERRATH. 2005. How viral infections affect the autoimmune process leading to type 1 diabetes. Cell Immunol. 233: 125-132.
45. LEE, C.-K. et al. 2005. Characterization of an infectious cDNAcopy of the genome of a naturally-occurring, avirulent coxsackievirus B3 clinical isolate. J. Gen. Virol. 86: 197-210.
46. TRACY, S., N.M. CHAPMAN, K.M. DRESCHER, et al. 2006. Evolution of virulence in picornaviruses. Curr. Topics Microbiol. Immunol. 299: 193-210.
47. TRACY, S., K.M. DRESCHER, N. CHAPMAN, et al. 2006. Evolution of virulence in picorna viruses. Curr. Top. Microbiol. Immunol. 299: 193-210.
48. SANDERS, L.J. 2002. From Thebes to Toronto and the 21st century: an incredible journey. Diabetes Spect. 15: 56-60.
49. ONKAMA, P., S. VAANANEN, M. KARVONEN & J. TUOMILEHTO. 1999. Worldwide increase in incidence of type 1 diabetes - the analysis of the data on published incidence trends. Diabetologia 42: 1395-1403.
50. GREEN, A. & C. PATTERSON. 2001. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 44(Suppl. 3): B3-B8.
51. BINGLEY, P. & E. GALE. 1989. Rising incidence of IDDM in Europe. Diabetes Care 12: 289-295.
52. NATHANSON, N. & J. MARTIN. 1979. The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am. J. Epidemiol. 110: 672-692.
53. NATHANSON, N., K.A. MCGANN, J. WILESMITH, et al. 1993. The evolution of virus diseases: their emergence, epidemicity, and control. Virus Res. 29: 3-20.
54. BUNIMOVICH-MENDRAZITSKY, S. & L. STONE. 2005. Modeling polio as a disease of development. J. Theor. Biol. 237: 302-315.
55. DORMAN, J. & C.H. BUNKER. 2000. HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. Epidemiol. Rev. 22: 218-227.
56. CHERUBINI, V. et al. 1999. Large incidence variation of type 1 diabetes in central-southern Italy 1990-1995: lower risk in rural areas. Diabetologia 42: 789-792.
57. VISKARI, H.R. et al. 2000. Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care 23: 414-416.
58. VERGE, C. et al. 1994. Environmental factors in childhood IDDM: a population-based, case-control study. Diabetes Care 17: 1381-1389.
59. STAINES, A. et al. 1997. Small area variation in the incidence of childhood insulin dependent diabetes mellitus in Yorkshire, UK: links with overcrowding and population density. Int. J. Epidemiol. 26: 1307-1313.
60. PATTERSON, C.J., D. CARSON & D. HADDEN. 1996. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group. Diabetologia 39: 1063-1069.
61. PARSLOW, R., P. MCKINNEY, G. LAW & H. BODANSKY. 2001. Population mixing and childhood diabetes. Int. J. Epidemiol. 30: 533-538.
62. MCKINNEY, P. et al. 2000. Early social mixing and childhood type 1 diabetes mellitus: a case control study in Yorkshire, UK. Diabet. Med. 17: 236-242.
63. KARVONEN, M., J. TUOMILEHTO, I. LIBMANN & R. LAPORTE. 1993. A review of the recent epidemiological data on the worldwide incidence of Type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia 36: 883-892.
64. KOLB, H. & R.B. ELLIOTT. 1994. Increasing incidence of IDDM a consequence of improved hygiene? Diabetologia 37: 729-731.